The Penicillins and Streptomycins dosage market in Australia has shown a varied progression from 2013 to 2023. Starting at $7.28 in 2013, the market per capita fluctuated slightly but demonstrated an upward trend, peaking at $10.89 in 2021. By 2023, the value stabilized at $10.14, reflecting sustainable demand in this sector. Over the last two years, there was a minor decline of 0.81%, and the compound annual growth rate (CAGR) over the past five years (2018-2023) was approximately 0.82%.
Future trends to watch include the potential impacts of emerging antibiotic formulations, regulatory changes, and shifts in healthcare policies, which may influence the demand and pricing of these antibiotics. Moreover, advancements in alternative therapeutics could alter market dynamics in the forthcoming years.
| # | 31 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 11.76 | 2023 | View data | ||
| 2 | 2 New Zealand | 11.59 | 2023 | View data | ||
| 3 | 3 France | 11.21 | 2023 | View data | ||
| 4 | 4 Belgium | 11.17 | 2023 | View data | ||
| 5 | 5 United Kingdom | 10.77 | 2023 | View data | ||
| 6 | 6 Australia | 10.14 | 2023 | |||
| 7 | 7 Canada | 7.4 | 2023 | View data | ||
| 8 | 8 Germany | 5.7 | 2023 | View data | ||
